Blackstone Holdings II L.P. 13D and 13G filings for Talaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:24 pm Purchase | 2021-12-31 | 13G | Talaris Therapeutics, Inc. TALS | Blackstone Holdings II L.P. | 808,932 19.600% | 808,932 (New Position) | Filing |